KCT0004258招募中未知
Real-world Efficacy and Safety of Immune check point inhibitors for Refractory Head and Neck Cancer: A Retrospective Multicenter Study
Chung-Ang Univerisity Hospital0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational Study
入排标准
- 年龄范围
- o Limit 至 o Limit（—）
- 性别
- All
入选标准
- •? Patients with larynx, oral cavity, oropharynx, nasal cavity, maxillary sinus, hypopharyngeal carcinoma confirmed histologically as squamous cell carcinoma
- •? Patients who have undergone palliative chemotherapy for relapse after surgery or initial metastasis
- •? Patients who have received immune checkpoint inhibitors
排除标准
- •? Nasopharyngeal cancer patients
- •? Patients who have not been observed after a single dose of immune checkpoint inhibitors (follow-up loss) are difficult to confirm the effects or adverse events
研究者
相似试验
招募中
Unknown
A real-world study of efficacy and safety of Immune check point inhibitors in patients with non-small cell lung cancer harboring driver oncogene excepting EGFRJPRN-UMIN000049022orth East Japan Study Group870
尚未招募
4 期
A clinical study to evaluate Immunity Booster Capules for boosting immunityCTRI/2020/10/028775Amitojas Wellness Private Limited
尚未招募
不适用
A Real World Evaluation of safety, immunogenicity and efficacy of COVID-19 Vaccines among health care workersCTRI/2021/01/030582Medanta Institute of Education and Research
尚未招募
不适用
Comparison of two routes of injection of MMR vaccine in the treatment of multiple wartsCTRI/2018/02/012128Indian association of Dermatologists Venereologists and leprologists West Bengal
进行中（未招募）
1 期
Evaluation of the benefits of Administering immunosuppressive drugs as Single daily doses over the first Year after liver transplantatiotransplantationCTIS2023-506601-19-00Centre Hospitalier Universitaire De Limoges200